期刊文献+

连续监测法测定血清丙氨酸氨基肽酶 被引量:4

A kinetic method for alanine aminopeptidase in serum
下载PDF
导出
摘要 目的 建立血清丙氨酸氨基肽酶 (AAP)连续监测法。方法 以丙氨酰对硝基苯胺 (Ala pNA)为底物 ,研究AAP作用于此底物的动力学特征 ,选择最适反应条件 ,建立血清AAP测定速率法及参考值 ,同时观测肝胆疾病患者血清AAP作用于此底物的动力学特征 ,选择最适反应条件 ,建立血清AAP测定速率法及参考值 ,同时观测肝胆疾病患者血清AAP水平。结果 酶反应最适pH8 0 ,Tris HCl缓冲液的最佳浓度 15 0mmol/L ,Ala pNa浓度以 3mmol/L为宜 ,米氏常数 (Km) 0 74mmol/L ,在 8min观测时间内吸光度变化与时间成比例 ,线性范围可达 180 0U/L ,平均批内、批间CV分别为 1 0 4%和 2 0 2 %。 2 0mmol/L甘油三酯、2g/L血红蛋白、340 μmol/L胆红素对酶活力测定无干扰 ,正常成年人群参考范围 ( x± 2s) 4 1~ 77U/L。肝胆疾病组血清AAP明显高于健康对照组。结论 血清AAP活力是鉴别诊断肝胆疾病的一项特异、灵敏的指标 ;连续监测法适用于各种类型的自动化分析仪 。 Objective To establish kinetic assay method for alanine aminopeptidase(AAP)in serum,be applied to clinical diagnosis primarily.Methods The kinetic property of AAP was studied with Ala pNA as substrate.It was optimized to the assay of serum AAP,and established the kinetic assay method and reference limits.Were determined AAP activity in serum of hepatobiliary disease subjects In the meantime.Results Optimum pH of assay for serum AAP was 8.0,concentration of Tris HCl buffer was 150 mmol/L,the final concentration of Ala pNA was 3 mmol/L.Michel Meten constant(Km)was 0.74 mmol/L.Absorbency increased along with time in 8 minutes at least.The linear limit extended to 1800 U/L.The withn run CV and among run CV was 1.04% and 2.02% respectively.The concentration of TG up to 20 mmol/L had noninterference to reaction,so did Hb up to 2g/L and T Bil up to 340 μmol/L.Reference limits for AAP in adults( ±2 s ) was 41~77 U/L.AAP values in serum was significantly higher for hepatobilary disease subjects than for healthy subjects.Conclusions: AAP in serum is a very specific and sensitive indicator of hepatobiliary disease.
出处 《临床检验杂志》 CAS CSCD 北大核心 2001年第6期334-336,共3页 Chinese Journal of Clinical Laboratory Science
关键词 丙氨酸氨基肽酶 连续监测法 肝胆疾病 血清检测 Alanine aminopeptidase Kinetic assay Hepatobiliary disease
  • 相关文献

参考文献2

二级参考文献6

  • 1[1] Mattenheimer H.Enzymes in renal diseases[J].Ann Clin Lab Sci,1977,7∶422-432.
  • 2关知次郎.アラニフアミノペプチダ—ゼ[J].日本临床,1995,(53增刊):445-446.
  • 3[3] Price R G.Urinary enzymes,nephrotoxicity and renal disease[J].Toxicology,1982,23∶99-134.
  • 4佐滕利彦,田中史郎,森井浩世.アラニンアミノペプチダ—ゼ(AAP)[J].日本临床,1998,(56增刊):329-335.
  • 5[5] Jung K,Scholz D.An optimized assay of alanine aminopeptidase activity in Urine[J].Clin Chem,1980,26∶1251-1254.
  • 6竹立精司,入江章子,田彰子,他.尿中Alanine aminopeptidase に关する检讨[J].临床病理,1986,(34):303-307.

共引文献1

同被引文献23

  • 1杜丽娜,孟宪镛,徐克成,叶林,姚登福.谷氨酰转肽酶、硷磷酶、亮氨酸氨基肽酶及其高分子酶测定在黄疸鉴别中的意义[J].临床肝胆病杂志,1989,5(4):205-208. 被引量:10
  • 2余比亚,陈光荣,何德秀.血清腺苷脱氨酶检测对病毒性肝炎的临床意义[J].江西医学检验,1998,16(4):189-190. 被引量:10
  • 3王家驹 袁顺玉 邹菊芳.血清腺苷脱氨酶测定对黄疸及肝纤维化的诊断价值[J].中华内科杂志,1986,25(2):79-79.
  • 4Dufour DR,Lott JA,Nolte FS,et al.Diagnosis and monitoring of hepatic injury.Ⅱ .Recomendations for use of laboratory tests in screening,diagnosis,and monitoring[J].Clin Chem,2000,46:2050.
  • 5Green RM,Flamm S.AGA technical review on the evaluation of liver chemistry tests[J].Gastroenterology,2002,123:1367.
  • 6Mueller PW,Philips DL,Steinbery KK.Alanine aminopeptidase in serum:automated optimized assay and effects of age,sex,smoking and alcohol consumption in a selected population[J].Clin Chem,1987,33/3:363.
  • 7Iwaki-Egawa S,Watanabe Y.Characterization and purification of adenosine deaminase from human and chicken liver[J].Coup Biochem Physiol B Biochem Mol Biol,2002,133(2):173.
  • 8MAR CINKIEWICIJ.Neutropil chloramines:missing links between innate and acquired immunity[J].Immunol Today,1997,18(12):577.
  • 9GOLDBEIG M D.serum adenosine deaminase activity in the differential diagnosis of jaundice[J].Br Med J,1965,1:353.
  • 10Obata K,Iwata K,Ichida T,et al.One step sandwich enzyme immunoassay for human type Ⅳ collagen using monoclonal antibodies[J].Clin Chem Acta,1989,181:293.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部